VALSECCHI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.145
AS - Asia 2.477
EU - Europa 2.453
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 211
AF - Africa 63
OC - Oceania 16
Totale 10.787
Nazione #
US - Stati Uniti d'America 5.027
CN - Cina 1.018
SG - Singapore 752
PL - Polonia 487
UA - Ucraina 419
IT - Italia 395
BR - Brasile 357
DE - Germania 339
HK - Hong Kong 187
GB - Regno Unito 173
FI - Finlandia 167
VN - Vietnam 167
FR - Francia 139
IN - India 106
RU - Federazione Russa 105
IE - Irlanda 75
TR - Turchia 69
CA - Canada 66
BD - Bangladesh 34
MX - Messico 27
CZ - Repubblica Ceca 26
BE - Belgio 24
ID - Indonesia 22
SE - Svezia 21
JP - Giappone 20
SA - Arabia Saudita 19
IQ - Iraq 17
AR - Argentina 16
NL - Olanda 16
ZA - Sudafrica 16
AT - Austria 13
AU - Australia 12
CO - Colombia 12
ES - Italia 12
EC - Ecuador 11
HU - Ungheria 10
NG - Nigeria 10
PK - Pakistan 9
IR - Iran 8
KE - Kenya 8
MA - Marocco 8
VE - Venezuela 8
UZ - Uzbekistan 7
EG - Egitto 6
JO - Giordania 6
PH - Filippine 6
UY - Uruguay 6
A1 - Anonimo 5
CH - Svizzera 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
AL - Albania 4
DZ - Algeria 4
EU - Europa 4
IL - Israele 4
JM - Giamaica 4
KG - Kirghizistan 4
PT - Portogallo 4
CL - Cile 3
CR - Costa Rica 3
HN - Honduras 3
LT - Lituania 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BH - Bahrain 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
SI - Slovenia 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
OM - Oman 1
Totale 10.579
Città #
Fairfield 487
Warsaw 483
Ashburn 481
Singapore 394
Woodbridge 371
Jacksonville 314
Ann Arbor 260
Houston 241
Chandler 230
Beijing 193
New York 191
Hong Kong 187
San Jose 184
Seattle 179
Wilmington 178
The Dalles 174
Cambridge 167
Princeton 137
Helsinki 112
Nanjing 98
Los Angeles 82
Dearborn 80
Dublin 75
Brescia 74
Lauterbourg 64
Munich 63
Istanbul 58
Milan 57
Shenyang 50
Jinan 49
Des Moines 47
Nanchang 44
Moscow 43
Ho Chi Minh City 41
Chicago 39
Dallas 38
Boardman 36
Changsha 36
São Paulo 36
Tianjin 36
Columbus 34
Hebei 34
Lancaster 34
Hanoi 33
Santa Clara 32
San Francisco 29
Buffalo 28
Council Bluffs 28
Redondo Beach 27
Shanghai 26
Orem 25
Turku 24
Jiaxing 23
London 23
Rome 21
Dong Ket 20
Guangzhou 19
San Diego 19
Brussels 18
Zhengzhou 18
Montreal 17
Ningbo 17
Brooklyn 16
Chennai 16
Lanzhou 16
Tokyo 16
Toronto 16
Brno 15
Atlanta 14
Manchester 14
Washington 14
Denver 13
Haikou 13
Phoenix 13
Frankfurt am Main 12
Norwalk 12
Hangzhou 11
Mexico City 11
Taizhou 11
Verona 11
Abuja 10
Boston 10
Olomouc 10
Charlotte 9
Jakarta 9
Kunming 9
Orange 9
Rio de Janeiro 9
Vienna 9
Belo Horizonte 8
Hefei 8
Johannesburg 8
New Delhi 8
Salvador 8
San Mateo 8
Stockholm 8
Taiyuan 8
Trieste 8
Da Nang 7
Fuzhou 7
Totale 7.072
Nome #
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 324
New Copy Number Variations in Schizophrenia 321
Farmacoterapia antipsicotica e disturbi cognitivi. 250
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 235
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial. 209
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 209
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 201
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 200
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 188
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 187
Comparison of quetiapine, olanzapine and risperidone in schizophrenia. 186
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 185
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 184
Analysis of Copy Number Variations in Schizophrenia Italian Patients 177
Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study. 177
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 176
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 176
Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia. 175
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 168
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 164
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 164
Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia. 163
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 161
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 159
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study 158
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 156
The role of the cytochine network in schizophrenia: an overview. 156
Patterns of Brain Structural Changes in First-Contact, Antipsychotic Drug-Naive Patients with Schizophrenia. 151
A multimodal imaging study of never-medicated adults with schizophrenia 150
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 149
Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder 146
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 145
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 145
Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial. 144
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 142
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 140
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 140
Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report. 137
Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample 137
Manuale di clinica e riabilitazione psichiatrica. Dalle conoscenze teoriche alla pratica dei servizi di salute mentale. Vol. 2: Riabilitazione psichiatrica 136
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 134
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 134
Immediate and 8-Month Impact of a Medical Educational Course for General Practitioners on Knowledge About Schizophrenia and Its Treatment: Results of a 3-Phase Study From Brescia, Italy. 132
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review 132
Detection of high level of autozygosity in a group of Italian schizophrenia patients 131
Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia 130
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 128
Relationship of IQ to neuropsychological tasks involving prefrontal cortex in schizophrenia. 128
Cerebrovascular accidents in elderly people treated with antipsychotic drugs. A systematic review 128
Comparison of quetiapine, olanzapine and risperidone in a randomized study in patients with schizophrenia. 127
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 126
New Copy Number Variations in Schizophrenia Italian Patients 125
Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia. 125
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 124
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 119
Mitochondrial DNA haplogroups and age at onset of schizophrenia 117
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 115
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 115
Implementing cognitive rehabilitation interventions for schizophrenia patients in mental health services: Focus on Integrated Psychological Therapy (IPT) 113
Panic disorder with and without comorbidity: data on epidemiology, course and treatment outcome. 111
Genome-Wide pharmacogenomics analysis of early antipsychotic (risperidone) response in patients with schizophrenia 110
Esperienze di switch a cariprazina in pazienti affetti da schizofrenia con ricorrenze 110
Paliperidone extended-release in the short- and long-term treatment of schizophrenia 108
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 108
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 98
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study 95
A miR-137–Related Biological Pathway of Risk for Schizophrenia Is Associated With Human Brain Emotion Processing 95
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 94
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features 93
La comorbidità per uso di sostanze nei disturbi psicotici e nella schizofrenia. 83
Paliperidone palmitate in short- and long-term treatment of schizophrenia 77
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 76
THE FACTOR STRUCTURE FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) IN PHARMACOGENETICS: 102T/C 5-HT2A POLYMORPHISM AND RESPONSE TO RISPERIDONE 75
Totale 10.787
Categoria #
all - tutte 47.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022532 0 105 15 32 7 23 27 33 28 58 56 148
2022/2023639 86 9 6 68 46 176 4 67 96 11 40 30
2023/2024777 41 14 70 82 46 196 31 21 119 29 18 110
2024/20251.344 19 30 15 171 154 129 96 52 133 82 272 191
2025/20262.766 263 354 212 421 322 220 388 99 117 243 79 48
2026/2027153 97 56 0 0 0 0 0 0 0 0 0 0
Totale 10.787